1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors. (2nd December 2019) Authors: Kapp, Kerstin; Volz, Barbara; Oswald, Detlef; Wittig, Burghardt; Baumann, Matthias; Schmidt, Manuel Journal: Oncoimmunology Issue: Volume 8:Number 12(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dendritic cells from human mesenteric lymph nodes in inflammatory and non‐inflammatory bowel diseases: subsets and function of plasmacytoid dendritic cells. Issue 1 (8th April 2013) Authors: Hostmann, Arwed; Kapp, Kerstin; Beutner, Marianne; Ritz, Jörg‐Peter; Loddenkemper, Christoph; Ignatius, Ralf; Duchmann, Rainer; Daum, Severin; Gröne, Jörn; Hotz, Hubert; Buhr, Heinz‐Johannes; Zeitz, Martin; Ullrich, Reiner Journal: Immunology Issue: Volume 139:Issue 1(2013:May) Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Distinct immunological activation profiles of dSLIM® and ProMune® depend on their different structural context. Issue 4 (18th October 2016) Authors: Kapp, Kerstin; Schneider, Jacqueline; Schneider, Lisa; Gollinge, Nadine; Jänsch, Stefanie; Schroff, Matthias; Wittig, Burghardt; Kleuss, Christiane Journal: Immunity, inflammation and disease Issue: Volume 4:Issue 4(2016) Page Start: 446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy. Issue 1 (8th January 2019) Authors: Kapp, Kerstin; Volz, Barbara; Curran, Michael A.; Oswald, Detlef; Wittig, Burghardt; Schmidt, Manuel Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Mode of action of maintenance immunotherapy therapy with the TLR-9 agonist MGN1703 in metastatic colorectal carcinoma: the Phase III IMPALA study. (4th November 2015) Authors: Stein, Alexander; Kapp, Kerstin; Scheithauer, Werner; Salazar, Ramon; Ducreux, Michel; Waddell, Tom; Arnold, Dirk; Tournigand, Christophe; Sobrero, Alberto; Van Cutsem, Eric; Schmidt, Manuel; Cunningham, David Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Mode of action of maintenance immunotherapy therapy with the TLR-9 agonist MGN1703 in metastatic colorectal carcinoma: the Phase III IMPALA study. Issue 2 (December 2015) Authors: Stein, Alexander; Kapp, Kerstin; Scheithauer, Werner; Salazar, Ramon; Ducreux, Michel; Waddell, Tom; Arnold, Dirk; Tournigand, Christophe; Sobrero, Alberto; Van Cutsem, Eric; Schmidt, Manuel; Cunningham, David Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗